Combined intravenous/intraarterial compared with Intraarterial recombinant tissue plasminogen activator in acute ischemic stroke: Propensity score analysis

被引：0
|
作者：
Zaidat, OO
Welter, E
Love, TE
Tarr, RW
Sunshine, JL
Landis, DMD
Selman, WR
Enterline, DS
Smith, TP
Alexander, MJ
机构：
来源：
JOURNAL OF NEUROSURGERY | 2004年 / 100卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [31] Successful intraarterial recombinant tissue plasminogen activator therapy for acute embolic occlusion of the superior mesenteric artery
    Sheeran S.R.
    Sclafani S.J.A.
    Emergency Radiology, 2001, 8 (3) : 152 - 155
  • [32] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [33] Safety and efficacy of intravenous tissue plasminogen activator in acute ischemic stroke
    Rajapa, S.
    Sivakumar, S.
    Arjundas, D.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 133 - 133
  • [34] Combined intra-venous and intra-arterial versus intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke patients: Propensity score analysis
    Zaidat, OO
    Welter, E
    Suarez, JI
    Kocharian, N
    Suri, FMK
    Alexander, MJ
    Landis, DMD
    Selman, WR
    Sunshine, J
    Tarr, R
    NEUROLOGY, 2004, 62 (07) : A465 - A465
  • [35] Cost utility analysis of intravenous tissue plasminogen activator in acute ischemic stroke in Canada
    Demaerschalk, BM
    Silver, B
    Merino, JG
    Wong, E
    Hill, MD
    Poncha, F
    Foell, B
    Tamayo, A
    Buchan, AM
    Hachinski, V
    STROKE, 2003, 34 (01) : 248 - 249
  • [36] Safety of combined standard intravenous dose of tPA followed by intraarterial tPA compared with Intraarterial tPA alone in acute ischemic stroke: Is dose reduction in bridging therapy necessary?
    Nogueira, RG
    Hoh, BL
    O'Donnell, J
    Pryor, JC
    Rabinov, JD
    Hirsch, JA
    Rordorf, GA
    Buonanno, FS
    Koroshetz, WJ
    Schwamm, LH
    JOURNAL OF NEUROSURGERY, 2004, 100 (01) : A199 - A199
  • [37] Safety and Effectiveness of Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients on Aspirin and Clopidogrel
    Qureshi, Mushtaq H.
    Khan, Shayaan M.
    Jahangir, Nauman
    Malik, Ahmed A.
    Freese, Melissa
    Thompson, Michelle
    Khan, Asif A.
    Suri, M. Fareed K.
    Qureshi, Adnan I.
    STROKE, 2015, 46
  • [38] Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Myocardial Infarction.
    Inohara, Taku
    Liang, Li
    Kosinski, Andrzej
    Smith, Eric E.
    Schwamm, Lee H.
    Hernandez, Adrian F.
    Bhatt, Deepak L.
    Fonarow, Gregg C.
    Peterson, Eric D.
    Xian, Ying
    STROKE, 2019, 50
  • [39] Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke
    Laible, Mona
    Jenetzky, Ekkehardt
    Moehlenbruch, Markus
    Ringleb, Peter Arthur
    Rizos, Timolaos
    EUROPEAN NEUROLOGY, 2015, 74 (3-4) : 127 - 134
  • [40] Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
    Chapman, Sherita N.
    Mehndiratta, Prachi
    Johansen, Michelle C.
    McMurry, Timothy L.
    Johnston, Karen C.
    Southerland, Andrew M.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 75 - 87
12345